prostate cancer Archives - Express Pharma

XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer: Phase 3 EMBARK Trial

Radiopharmaceuticals for prostate cancer to go nuclear with $6.3 bn in sales by 2030

Zydus launches Rexigo, oral once-a-day pill to treat advanced prostate cancer

BDR Pharma launches BDENZA oral solution for prostate cancer

BDR Pharma launches generic Rucaparib to treat advanced ovarian and prostate cancers

LYNPARZA (olaparib) get three new approvals in Japan

Sheffield University gets £3.1 mn for trials to better bladder, prostate cancer diagnosis, treatment

BDR Pharma launches 80mg of Enzalutamide for prostate cancer treatment

AstraZeneca gets DCGI nod to import and market Olaparib film coated tablets